CPT codes Concert Genetics New Test ID Tool Works to Improve Reimbursement Process Premium The company previously launched its Concert Coding Engine to help standardize how genetic tests are coded and how labs can bill for them. Diaceutics, Alva10 Gathering Evidence Base for Improving PD-L1 Test Reimbursement Premium The companies will work with labs to improve payors' understanding of the costs of performing PD-L1 testing and the value it provides to patient care. Palmetto Cease-and-Desist Letter to Reimbursement Expert Raises Questions About Pricing Transparency Premium As government lab spending grows, the Medicare contractor has barred access to a coding and pricing file obtained via FOIA claiming it holds business secrets. CMS Increases Payment Rates for High-Throughput SARS-CoV-2 Tests The new rate applies to clinical diagnostic lab tests using high-throughput technologies that can process more than 200 specimens per day. Myriad Genetics Fiscal Q1 Revenues Drop 8 Percent on Hereditary Cancer Testing Coding Challenges The company had a challenging fiscal first quarter due to the deletion of CPT codes that payors used to use to reimburse hereditary cancer testing. Sep 6, 2019 Concert Genetics Launches Software to Limit Coding Variability in Genetic Testing Premium Jan 4, 2019 Pathologist Group Asks Medicare to Reconsider Payment for BRCA Genetic Testing CPT Codes Dec 27, 2018 Epigenomics Pushes New Promotion Efforts for ProColon Test as Other Assays in Pipeline Advance Premium Sep 18, 2017 AMA Quickly Issuing New Proprietary Analyses Codes, but Will They Improve MDx Reimbursement? Premium Dec 22, 2016 NGS Test Coding Changes Slated for Discussion at 2017 CPT Editorial Panel Meeting Apr 19, 2016 Invitae's Breast Cancer Tests Get New Medicare Reimbursement Code Dec 2, 2015 Amid PAMA Implementation, Stakeholders Contemplate Coding to Facilitate Market-Based MDx Pricing Premium May 29, 2015 CMS Contractors Issue Prices for Few MDx CPT Codes; Most Large Sequencing Panels Remain Unpriced Oct 15, 2014 CMS Issues Preliminary Lab Fee Schedule Determinations for Genomic Testing CPT Codes Premium Jul 2, 2014 Palmetto GBA Issues Three Draft LCDs on Multi-marker Tests; MolDx Lays out Review Criteria, Process Premium Apr 2, 2014 Market-based Reimbursement Provisions for Lab Tests in HR 4302 Passes Senate with Industry Backing Premium Dec 24, 2013 Top PGx Reporter Stories of 2013 Focus on Reimbursement, Regulation, Gene Patenting Premium Dec 11, 2013 In 2014 Final Rule, CMS Plans Annual Technology Reviews to Establish Payment Accuracy for Lab Tests Premium Oct 23, 2013 Transgenomic Enlists PDI to Market Cardiac PGx Test; PDI Entering MDx Space Premium Oct 16, 2013 MDxHealth's MGMT Dx May Benefit from NCCN Support for Assessing Methylation Status in Glioblastoma Premium Oct 2, 2013 CMS National Payment Limit for Tier 1 Codes Not as Low as Before, but Challenges Remain Premium Oct 2, 2013 CMS Still Unwilling to Pay for Algorithm Portion of Multi-analyte Algorithm-based Assays Premium Sep 18, 2013 Amid Deepening Reimbursement Challenges, MDx-Focused Bill MODDERN Revived in Congress Premium Jul 31, 2013 Q&A: GE's Orrin Marcella Discusses Coalition to Strengthen the Future of Molecular Diagnostics Premium May 22, 2013 CMS Issues Pricing for MDx Codes; Labs, Test Developers Still Critical of Rates and Methodology Premium Load More Breaking News Cancer Prognoses Informed by Module-Based Approach, Study Finds People in the News at Illumina, Centogene, BioSkryb New Products Posted to GenomeWeb: Bio-Rad, BD, Analytik Jena, BioMérieux Genetic Technologies to Raise A$5M in Direct Stock Offering In Brief This Week: SD Biosensors, Meridian, Oncocyte, Opko Health, GeneDx, More The Scan Study Reveals New Details About Genetics of Major Cause of Female Infertility Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency. Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis. Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven. White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.